Kallikrein 15 anticorps (AA 80-180)
Aperçu rapide pour Kallikrein 15 anticorps (AA 80-180) (ABIN3016615)
Antigène
Voir toutes Kallikrein 15 (KLK15) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 80-180
-
Séquence
- RDGPEQLRTT SRVIPHPRYE ARSHRNDIML LRLVQPARLN PQVRPAVLPT RCPHPGEACV VSGWGLVSHN EPGTAGSPRS QVSLPDTLHC ANISIISDTS C
-
Réactivité croisée
- Souris, Rat
-
Attributs du produit
- Polyclonal Antibodies
-
Immunogène
- Recombinant fusion protein containing a sequence corresponding to amino acids 80-180 of human KLK15 (NP_059979.2).
-
Isotype
- IgG
-
-
-
-
Indications d'application
- WB,1:500 - 1:2000
-
Restrictions
- For Research Use only
-
-
-
Buffer
- PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- Kallikrein 15 (KLK15) (Kallikrein-Related Peptidase 15 (KLK15))
-
Autre désignation
- KLK15
-
Sujet
- Kallikreins are a subgroup of serine proteases having diverse physiological functions. Growing evidence suggests that many kallikreins are implicated in carcinogenesis and some have potential as novel cancer and other disease biomarkers. This gene is one of the fifteen kallikrein subfamily members located in a cluster on chromosome 19. In prostate cancer, this gene has increased expression, which indicates its possible use as a diagnostic or prognostic marker for prostate cancer. The gene contains multiple polyadenylation sites and alternative splicing results in multiple transcript variants encoding distinct isoforms.,KLK15,ACO,HSRNASPH,Cancer,Invasion and Metastasis,Signal Transduction,Cell Biology & Developmental Biology,Cytoskeleton,Extracellular Matrix,Ubiquitin,KLK15
-
Poids moléculaire
- 13 kDa/17 kDa/19 kDa/28 kDa
-
ID gène
- 55554
-
UniProt
- Q9H2R5
-
Pathways
- Système du Complément
Antigène
-